Literature DB >> 25034560

Comprehensive analysis of inflammatory markers in chronic thromboembolic pulmonary hypertension patients.

Diana Zabini1, Akos Heinemann2, Vasile Foris1, Chandran Nagaraj1, Patrick Nierlich3, Zoltán Bálint1, Grazyna Kwapiszewska4, Irene M Lang5, Walter Klepetko3, Horst Olschewski6, Andrea Olschewski7.   

Abstract

Chronic thromboembolic pulmonary hypertension (CTEPH) is associated with chronic inflammation but the pathological mechanisms are largely unknown. Our study aimed to simultaneously profile a broad range of cytokines in the supernatant of pulmonary endarterectomy (PEA) surgical material, as well as prospectively in patients with CTEPH to investigate whether circulating cytokines are associated with haemodynamic and physical characteristics of CTEPH patients. Herein, we show that PEA specimens revealed a significant upregulation of interleukin (IL)-6, monocyte chemoattractant protein-1, interferon-γ-induced protein-10 (IP)-10, macrophage inflammatory protein (MIP)1α and RANTES compared to lung tissue from healthy controls. In prospectively collected serum, levels of IL-6, IL-8, IP-10, monokine induced by interferon-γ (MIG) and MIP1α were significantly elevated in CTEPH patients compared to age- and sex-matched healthy controls. In serum of idiopathic pulmonary arterial hypertension (IPAH) patients, only IP-10 and MIG were significantly increased. In CTEPH but not in IPAH, IP-10 was negatively correlated with cardiac index, 6-min walking distance and carbon monoxide diffusion capacity. In vitro, IP-10 significantly increased migration of freshly isolated adventitial fibroblasts. Our study is the first to show that IP-10 secretion is associated with poor pulmonary haemodynamics and physical capacity in CTEPH and might be involved in the pathological mechanism of PEA tissue formation. ©ERS 2014.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25034560     DOI: 10.1183/09031936.00145013

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  27 in total

1.  Chronic Embolic Pulmonary Hypertension Caused by Pulmonary Embolism and Vascular Endothelial Growth Factor Inhibition.

Authors:  Evandro M Neto-Neves; Mary B Brown; Maria V Zaretskaia; Samin Rezania; Adam G Goodwill; Brian P McCarthy; Scott A Persohn; Paul R Territo; Jeffrey A Kline
Journal:  Am J Pathol       Date:  2017-02-07       Impact factor: 4.307

Review 2.  A pro-con debate: current controversies in PAH pathogenesis at the American Thoracic Society International Conference in 2017.

Authors:  Wolfgang M Kuebler; Mark R Nicolls; Andrea Olschewski; Kohtaro Abe; Marlene Rabinovitch; Duncan Stewart; Stephen Y Chan; Nicholas W Morrell; Stephen L Archer; Edda Spiekerkoetter
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2018-06-07       Impact factor: 5.464

Review 3.  Chronic Thromboembolic Pulmonary Hypertension: the Bench.

Authors:  George A Alba; Deepak Atri; Sriranjani Darbha; Inderjit Singh; Victor F Tapson; Michael I Lewis; Hyung J Chun; Yen-Rei Yu; Bradley A Maron; Sudarshan Rajagopal
Journal:  Curr Cardiol Rep       Date:  2021-08-19       Impact factor: 2.931

4.  CXCL10 levels in diagnosis and improved hemodynamics in patients with chronic thromboembolic pulmonary hypertension undergoing balloon pulmonary angioplasty.

Authors:  Cheng Hong; Jianmin Lu; Riken Chen; Haimin Liu; Haiming Chen; Xiaofeng Wu; Wenliang Guo; Zijie Huang; Huizhao Liao
Journal:  Pulm Circ       Date:  2022-06-07       Impact factor: 2.886

5.  Platelet, Fibrinolytic and Other Coagulation Abnormalities in Newly-Diagnosed Patients with Chronic Thromboembolic Pulmonary Hypertension.

Authors:  Eleni Vrigkou; Argirios Tsantes; Dimitrios Konstantonis; Evdoxia Rapti; Eirini Maratou; Athanasios Pappas; Panagiotis Halvatsiotis; Iraklis Tsangaris
Journal:  Diagnostics (Basel)       Date:  2022-05-16

Review 6.  Epidemiology and Pathophysiology of Chronic Thromboembolic Pulmonary Hypertension: Risk Factors and Mechanisms.

Authors:  Sarah Medrek; Zeenat Safdar
Journal:  Methodist Debakey Cardiovasc J       Date:  2016 Oct-Dec

Review 7.  Role of oxidized lipids in pulmonary arterial hypertension.

Authors:  Salil Sharma; Grégoire Ruffenach; Soban Umar; Negar Motayagheni; Srinivasa T Reddy; Mansoureh Eghbali
Journal:  Pulm Circ       Date:  2016-09       Impact factor: 3.017

Review 8.  Current concepts in the pathogenesis of chronic thromboembolic pulmonary hypertension.

Authors:  Daniel T Matthews; Anna R Hemnes
Journal:  Pulm Circ       Date:  2016-06       Impact factor: 3.017

9.  NEDD9 Is a Novel and Modifiable Mediator of Platelet-Endothelial Adhesion in the Pulmonary Circulation.

Authors:  George A Alba; Andriy O Samokhin; Rui-Sheng Wang; Ying-Yi Zhang; Bradley M Wertheim; Elena Arons; Edward A Greenfield; Martina H Lundberg Slingsby; Julia R Ceglowski; Kathleen J Haley; Frederick P Bowman; Yen-Rei Yu; John C Haney; George Eng; Richard N Mitchell; Anthony Sheets; Sara O Vargas; Sachiko Seo; Richard N Channick; Peter J Leary; Sudarshan Rajagopal; Joseph Loscalzo; Elisabeth M Battinelli; Bradley A Maron
Journal:  Am J Respir Crit Care Med       Date:  2021-06-15       Impact factor: 21.405

Review 10.  In situ Pulmonary Artery Thrombosis: A Previously Overlooked Disease.

Authors:  Yunshan Cao; Chao Geng; Yahong Li; Yan Zhang
Journal:  Front Pharmacol       Date:  2021-07-08       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.